Financial Advocates Investment Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,651
Closed -$88.4K 794
2022
Q4
$88.4K Sell
12,651
-370
-3% -$3.81K 0.01% 723
2022
Q3
$116K Sell
13,021
-7,400
-36% -$85.4K 0.01% 714
2022
Q2
$211K Sell
20,421
-15,553
-43% -$231K 0.02% 609
2022
Q1
$750K Sell
35,974
-350
-1% -$7.63K 0.05% 356
2021
Q4
$930K Buy
+36,324
New +$1M 0.06% 335

Other funds holding MSOS

Financial Advocates Investment Management's MSOS Position: Q1 2023 in Review

Financial Advocates Investment Management sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q1 2023, closing a stake of 12,651 shares — an estimated $88.4K sold.

Financial Advocates Investment Management first reported a position in MSOS in Q4 2021 and held it in 5 quarters. The position peaked at $930K in Q4 2021. 175 funds tracked by Wall St. Rank hold MSOS as of Q1 2023.

  • Financial Advocates Investment Management reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q1 2023 after selling out during the quarter.
  • Financial Advocates Investment Management sold 12,651 AdvisorShares Pure US Cannabis ETF shares in Q1 2023, an estimated $88.4K.
  • Financial Advocates Investment Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2021 and held it in 5 quarters.
  • Financial Advocates Investment Management's AdvisorShares Pure US Cannabis ETF position peaked at $930K in Q4 2021.
  • 175 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2023.

Based on Financial Advocates Investment Management's 13F filing for Q1 2023, filed 11 May 2023.